openPR Logo
Press release

Muscle Relaxant Drugs Market Expected to Reach USD 6,057.60 Million by 2034, Growing at a CAGR of 4.1%

05-08-2025 12:18 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Muscle Relaxant Drugs Market

Muscle Relaxant Drugs Market

According to Polaris Market Research analysis, the global muscle relaxant drugs market was valued at USD 4,062.94 million in 2024 and is projected to reach USD 6,057.60 million by 2034, registering a compound annual growth rate (CAGR) of 4.1% from 2025-2034.

Market Explanation:
Muscle relaxants are medications that are utilized to prohibit and decrease muscle spasms and tightness. They take place when there is an unregulated shrinkage of a category of muscles. The muscles normally contract instantly. This is quite agonizing. Spasticity takes place when some muscles shrink tightly and then become hardened and stiffer to use. The majority of relaxant concoctions are obtainable as capsules, tablets, or liquids.

Download Free Sample PDF Copy of the Report:
http://www.polarismarketresearch.com/industry-analysis/muscle-relaxant-drugs-market/request-for-sample

Muscle relaxants function by bringing about the muscles to become less rigid or stiff which subsequently decreases pain and unease. Baclofen, diazepam, methocarbamol, and tizanidine act on the central nervous system, such as the brain and spinal cord. Dantrolene operates instantly on muscle spasm relief. As dantrolene functions only on the muscles, it is contemplated to possess lesser muscle relaxant drug side effects as compared to other muscle relaxants.

Market Growth Drivers:
Growing Elderly Population: The aging global population is creating new challenges for healthcare systems, especially in handling musculoskeletal well-being. Aged people are more liable to conditions such as osteoarthritis and lower back pain, which make everyday ventures arduous. To mitigate pain and enhance movability, there is a growing inclination towards relaxant medicines having a favorable impact on muscle relaxant drug market sales.

Economic Burden of Musculoskeletal Illnesses: Musculoskeletal illnesses not only impact a person's well-being but also inflict a notable economic load on societies. In the US, for instance, the yearly price for the treatment and lost stipends connected to MSDs was approximated at USD 213 million reckoning for 1.4% of the nation's gross domestic product. These statistics circumscribe direct medical disbursements and indirect prices, such as lost productivity due to impairment.

Request for a Discount on this Report Before Purchase:
http://www.polarismarketresearch.com/industry-analysis/muscle-relaxant-drugs-market/request-for-discount-pricing

Competitive Landscape:
Actively working to develop innovative and effective treatments for musculoskeletal disorders, the top market players allocate substantial resources to comprehensive research and development initiatives. Key companies are mentioned below:
• Abbott Laboratories
• Acorda Therapeutics, Inc.
• Ipsen Biopharmaceuticals, Inc.
• Lannett Company, Inc.
• Merck & Co., Inc.
• Neurana Pharmaceuticals, Inc.
• Pfizer Inc.
• Sandoz International GmbH
• Teva Pharmaceutical Industries Ltd.
• Unichem Laboratories Ltd.
• Zydus Group

Muscle Relaxant Drugs Industry Developments
• June 2024: The FDA granted fast-track designation to Tonmya (cyclobenzaprine HCl) for the treatment of fibromyalgia, following promising results from the Phase 3 RESILIENT study, which demonstrated significant pain reduction compared to a placebo.

• June 2022: Amneal's LYVISPAH (baclofen) oral granules were approved by the FDA for treating spasticity related to multiple sclerosis and spinal cord disorders. The formulation provides flexible dosing, offering an alternative for patients who have difficulty swallowing.

Explore The Complete Comprehensive Report Here:
http://www.polarismarketresearch.com/industry-analysis/muscle-relaxant-drugs-market

Regional Outlook:
Regional augmentation policies in the muscle relaxant drugs market are also important, with firms targeting emerging markets to benefit from the growing demand.

North America remains a dominant force supported by the region's advanced healthcare framework, heightened existence of musculoskeletal illnesses, and substantial funding in research and development.

Europe is witnessing steady growth, fuelled by an aging population and a heightened prevalence of musculoskeletal illnesses.

Buy Now:
http://www.polarismarketresearch.com/buy/2508/0

Segmental Division:
By Drug Type Outlook (Revenue-USD Million, 2020-2034)
• Skeletal Muscle Relaxant Drugs
• Facial Muscle Relaxant Drugs
• Neuromuscular Blocking Agents

By Route of Administration Outlook (Revenue-USD Million, 2020-2034)
• Oral
• Injectable

By Distribution Channel Outlook (Revenue-USD Million, 2020-2034)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Browse More Research Reports:
Single-Use Assemblies Market:
http://www.polarismarketresearch.com/industry-analysis/single-use-assemblies-market

Health Information Exchange Market:
http://www.polarismarketresearch.com/industry-analysis/health-information-exchange-market

Lewy Body Dementia Treatment Market:
http://www.polarismarketresearch.com/industry-analysis/lewy-body-dementia-treatment-market

Medical Equipment Maintenance Market:
http://www.polarismarketresearch.com/industry-analysis/medical-equipment-maintenance-market

Medical Foods Market:
http://www.polarismarketresearch.com/industry-analysis/medical-foods-market

Muscle Relaxant Drugs Market: A Much-Needed Relaxation to Muscle Functionality:
http://www.polarismarketresearch.com/blog/muscle-relaxant-drugs-market-share

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: http://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Muscle Relaxant Drugs Market Expected to Reach USD 6,057.60 Million by 2034, Growing at a CAGR of 4.1% here

News-ID: 4005542 • Views:

More Releases from Polaris Market Research & Consulting

Lab Automation Market Projected to Reach USD 14.68 Billion by 2034, Growing at a CAGR of 6.6%
Lab Automation Market Projected to Reach USD 14.68 Billion by 2034, Growing at a …
According to Polaris Market Research analysis, the global lab automation market was valued at USD 7.77 billion in 2024 and is projected to reach USD 14.68 billion by 2034, registering a compound annual growth rate (CAGR) of 6.6% from 2025-2034. Market Explanation: Laboratory automation systems are the incorporation of automated technology into the lab to enable contemporary and enhanced procedures. Normally, lab automation solutions automate the most mundane chores in labs, such
OEM Insulation Market Projected to Hit USD 28.97 Billion by 2034 with a CAGR of 5.4%
OEM Insulation Market Projected to Hit USD 28.97 Billion by 2034 with a CAGR of …
OEM Insulation Market According to Polaris Market Research analysis, the global OEM insulation market was valued at USD 17.15 billion in 2024. It is projected to reach USD 28.97 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2034. Market Preface Original equipment manufacturer (OEM) insulation is an important constituent in several industries where thermal management is predominant. This specific insulation is designed for integration into
Canadian Oilfield Chemicals Market to Reach USD 2,436.47 Million by 2034, Growing at a CAGR of 3.7%
Canadian Oilfield Chemicals Market to Reach USD 2,436.47 Million by 2034, Growin …
Canadian Oilfield Chemicals Market The Canadian oilfield chemicals market in terms of revenue was estimated to be worth USD 1,696.69 million in 2024. It is poised to reach USD 2,436.47 million by 2034, exhibiting a CAGR of 3.7% from 2025 to 2034. What Are Oilfield Chemicals? Oilfield production chemicals are chemical constituents of several compounds that are administered in oil and gas extraction operations to enhance them by improving the productivity and efficacy
Peptide Synthesis Market Expected to Reach USD 2,175.91 Million by 2034, Growing at a CAGR of 12.4%
Peptide Synthesis Market Expected to Reach USD 2,175.91 Million by 2034, Growing …
The peptide synthesis market is expected to gain market growth during the forecast period of 2025 to 2034. Polaris Market Research analyses the market to account for USD 2,175.91 million by 2034 and is expected to register a CAGR of 12.4% in the above-mentioned forecast period. The market was valued at USD 679.93 million in 2024. Market Definition A peptide comprises two or more amino acids connected by an amide bond to

All 5 Releases


More Releases for Muscle

Muscle Sculpting Market size valued at USD 189.8 Million in 2021 Owing to Growin …
According to the Precision Business Insights, the global muscle-sculpting market is segmented By Technology (Electromagnetic Stimulation and Electrical Muscle Stimulation) By Application (Abdominal, Thighs, Buttocks, Arms, Calves, Flanks, and Others), and By End-User (Fitness Club, Physical Therapy, Chiropractor, Aesthetic Physicians, Sports Medicine, and Pain Management, Directly to Customers (B2C), and Others) and Geography - The global muscle-sculpting market was valued at USD 189.9 million in 2021, growing at a significant
Truflexen Muscle Builder Review: (Shocking Truth!) Read this Truflexen Muscle Bu …
As men get older, testosterone levels begin to drop. In fact, after age 30, your testosterone levels drop by 2-4% per year. If you are looking for an edge, a secret weapon, that will help you push harder and maximize your potential... Well, we are here to help. Truflexen Muscle Builder is a safe way to help support your body’s natural production of testosterone. Almost every man can benefit from
Global Muscle Stimulators Market Forecast till 2025
eSherpa Market Reports added a new market research report on 'Global Muscle Stimulators Market, 2020-2025' to its database of market research collaterals consisting of complete market scenario with prevailing and future growth prospects, among other growth strategies used by important players to stay ahead of the game. Additionally, recent trends, mergers and acquisitions, region-wise growth analysis along with challenges that are affecting the growth of the market are also stated
Europe Muscle Stimulation Devices Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Europe Muscle Stimulation Devices Market Report 2017" Description This report studies sales (consumption) of Muscle Stimulation Devices in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering DJO Global Zynex NeuroMetrix RS Medical Omron Market Segment by Countries, this report splits Europe into several key Countries, with
Global Muscle Relaxants Industry 2016 Market Study of Top Muscle Relaxants : Pfi …
The global Muscle Relaxants market has been thoroughly explained in this market intelligence document. It involves discussions on the key factors that surround the growth rate of the global Muscle Relaxants market, while using primary and secondary methods of research. The research report therefore focuses on offering a wide-angled analytical perspective on the global Muscle Relaxants market. The report also takes up the explanation of the key components of the
Muscle Beach® Comes to the Carolinas
Muscle Beach®, the iconic fitness brand that single-handedly jumpstarted the fitness revolution, has converted a former Nautilus Fitness Center in Orangeburg South Carolina to their prestigious brand. Wilbraham, MA, July 19, 2011 -- Muscle Beach®, the iconic fitness brand that single-handedly jumpstarted the fitness revolution, has converted a former Nautilus Fitness Center in Orangeburg South Carolina to their prestigious brand. “As the entity that led to the establishment of Gold's Gym® and